First UK Debt Financing Fund For Life Sciences Raises $762m

30 Mar 2017

• By John Davis

The first life sciences-focused specialized investment fund, BioPharma Credit, has completed an IPO in London, lifting the spirits of the investment community pondering the long-term consequences of the country withdrawing from the EU.

A specialized investment fund, BioPharma Credit, started trading on the London Stock Exchange on March 30, following a substantial initial public offering (IPO) that raised double its initial target and answering those calling for the UK to build up its financial “ecosystem” for life science companies.

BioPharma Credit is the first fund specializing in debt financing for the life sciences industry to be listed on the...